Literature DB >> 35436389

von Willebrand factor as an indicator of endothelial injury in COVID-19: comment on the article by Shi et al.

Darryl E Palmer-Toy1, Timothy M Cotter1, Hedyeh Shafi1, Su-Jau T Yang1, Alexander H Cotter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35436389      PMCID： PMC9082476          DOI： 10.1002/art.42142

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   15.483


× No keyword cloud information.
  9 in total

1.  Elevated von Willebrand Factor Antigen Is an Early Predictor of Mortality and Prolonged Length of Stay for Coronavirus Disease 2019 (COVID-19) Inpatients.

Authors:  Alexander H Cotter; Su-Jau T Yang; Hedyeh Shafi; Timothy M Cotter; Darryl Erik Palmer-Toy
Journal:  Arch Pathol Lab Med       Date:  2022-01-01       Impact factor: 5.534

Review 2.  Von Willebrand factor, platelets and endothelial cell interactions.

Authors:  Z M Ruggeri
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

3.  Endothelial Cell-Activating Antibodies in COVID-19.

Authors:  Hui Shi; Yu Zuo; Sherwin Navaz; Alyssa Harbaugh; Claire K Hoy; Alex A Gandhi; Gautam Sule; Srilakshmi Yalavarthi; Kelsey Gockman; Jacqueline A Madison; Jintao Wang; Melanie Zuo; Yue Shi; Michael D Maile; Jason S Knight; Yogendra Kanthi
Journal:  Arthritis Rheumatol       Date:  2022-05-27       Impact factor: 15.483

Review 4.  Vasculitis update: pathogenesis and biomarkers.

Authors:  Paul Brogan; Despina Eleftheriou
Journal:  Pediatr Nephrol       Date:  2017-08-07       Impact factor: 3.714

5.  ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.

Authors:  R Escher; N Breakey; B Lämmle
Journal:  Thromb Res       Date:  2020-05-23       Impact factor: 3.944

6.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Authors:  Julie Helms; Charles Tacquard; François Severac; Ian Leonard-Lorant; Mickaël Ohana; Xavier Delabranche; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Florence Fagot Gandet; Samira Fafi-Kremer; Vincent Castelain; Francis Schneider; Lélia Grunebaum; Eduardo Anglés-Cano; Laurent Sattler; Paul-Michel Mertes; Ferhat Meziani
Journal:  Intensive Care Med       Date:  2020-05-04       Impact factor: 17.440

7.  Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.

Authors:  Aurélien Philippe; Richard Chocron; Nicolas Gendron; Olivier Bory; Agathe Beauvais; Nicolas Peron; Lina Khider; Coralie L Guerin; Guillaume Goudot; Françoise Levasseur; Christophe Peronino; Jerome Duchemin; Julie Brichet; Elise Sourdeau; Florence Desvard; Sébastien Bertil; Frédéric Pene; Cherifa Cheurfa; Tali-Anne Szwebel; Benjamin Planquette; Nadia Rivet; Georges Jourdi; Caroline Hauw-Berlemont; Bertrand Hermann; Pascale Gaussem; Tristan Mirault; Benjamin Terrier; Olivier Sanchez; Jean-Luc Diehl; Michaela Fontenay; David M Smadja
Journal:  Angiogenesis       Date:  2021-01-15       Impact factor: 10.658

8.  Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.

Authors:  A Marco; P Marco
Journal:  J Thromb Thrombolysis       Date:  2021-04-17       Impact factor: 2.300

Review 9.  VWF, Platelets and the Antiphospholipid Syndrome.

Authors:  Shengshi Huang; Marisa Ninivaggi; Walid Chayoua; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.